Two chemo cycles sufficient prior to HSCT in MRD-negative acute myeloid leukaemia
02 Jul 2026
byJairia Dela Cruz
For children and young adults with acute myeloid leukaemia (AML) and measurable residual disease (MRD) negativity, proceeding to allogeneic hematopoietic stem cell transplant (HSCT) after two rounds of chemotherapy is as effective as completing a third cycle prior to HSCT, yielding similar transplant outcomes, according to a multicentre retrospective study.
